Cargando…
Cost-effectiveness of folic acid therapy for primary prevention of stroke in patients with hypertension
BACKGROUND: For hypertensive patients without a history of stroke or myocardial infarction (MI), the China Stroke Primary Prevention Trial (CSPPT) demonstrated that treatment with enalapril-folic acid reduced the risk of primary stroke compared with enalapril alone. Whether folic acid therapy is an...
Autores principales: | Zhang, Tiantian, Liang, Zhuoru, Lin, Tengfei, Cohen, David J., Arrieta, Alejandro, Wang, Xiaobin, Qin, Xianhui, Wang, Binyan, Huo, Yong, Liu, Gordon G., Jiang, Jie, Zhang, Zugui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9594871/ https://www.ncbi.nlm.nih.gov/pubmed/36280851 http://dx.doi.org/10.1186/s12916-022-02601-z |
Ejemplares similares
-
Interaction of Serum Alkaline Phosphatase and Folic Acid Treatment on Chronic Kidney Disease Progression in Treated Hypertensive Adults
por: Zhang, Yuanyuan, et al.
Publicado: (2022) -
Positive Association Between Serum Alkaline Phosphatase and First Stroke in Hypertensive Adults
por: Zhang, Yuanyuan, et al.
Publicado: (2021) -
Change in the Estimated Glomerular Filtration Rate Over Time and Risk of First Stroke in Hypertensive Patients
por: He, Panpan, et al.
Publicado: (2023) -
Proteinuria Is an Independent Risk Factor for First Incident Stroke in Adults Under Treatment for Hypertension in China
por: Zhang, Chunyan, et al.
Publicado: (2015) -
Association Between Folic Acid Supplementation and Retinal Atherosclerosis in Chinese Adults With Hypertension Complicated by Diabetes Mellitus
por: Meng, Ying, et al.
Publicado: (2018)